drugset / Trial / NCT00591084

Ginsenoside-Rd for Acute Ischemic Stroke

NCT00591084 ↗

Phase 2 Completed 199 enrolled Xijing Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.

Timeline

Start
2005-09
Primary completion
2006-06
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject ginsenoside-Rd Unknown 10 mg Other
Subject ginsenoside-Rd Unknown 20 mg Other

Indications